Literature DB >> 28450579

Characterization of the Tissue Distribution of the Mouse Cyp2c Subfamily by Quantitative PCR Analysis.

Joan P Graves1, Artiom Gruzdev1, J Alyce Bradbury1, Laura M DeGraff1, Matthew L Edin1, Darryl C Zeldin2.   

Abstract

The CYP2C subfamily of the cytochrome P450 gene superfamily encodes heme-thiolate proteins that have a myriad of biologic functions. CYP2C proteins detoxify xenobiotics and metabolize endogenous lipids such as arachidonic acid to bioactive eicosanoids. We report new methods and results for the quantitative polymerase reaction (qPCR) analysis for the 15 members of the mouse Cyp2c subfamily (Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c40, Cyp2c44, Cyp2c50, Cyp2c54, Cyp2c55, Cyp2c65, Cyp2c66, Cyp2c67, Cyp2c68, Cyp2c69, and Cyp2c70). Commercially available TaqMan primer/probe assays were compared with developed SYBR Green primer sets for specificity toward the mouse Cyp2c cDNAs and analysis of their tissue distribution. TaqMan primer/probe assays for 10 of the mouse Cyp2c isoforms were shown to be specific for their intended mouse Cyp2c cDNA; however, there were no TaqMan primer/probe assays specific for the mouse Cyp2c29, Cyp2c40, Cyp2c67, Cyp2c68, or Cyp2c69 transcripts. Each of the SYBR Green primer sets was specific for its intended mouse Cyp2c cDNA. The two qPCR methods confirmed similar patterns of Cyp2c tissue expression: Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c44, Cyp2c50, Cyp2c54, and Cyp2c70 were most highly expressed in liver; Cyp2c55 was highly expressed in large intestine; Cyp2c65 was highly expressed in stomach, duodenum, and large intestine; and Cyp2c66 was highly expressed in both duodenum and jejunum. For isoforms without specific TaqMan primer/probe assays, the SYBR Green primer sets detected high level expression of Cyp2c29, Cyp2c40, Cyp2c67, Cyp2c68, and Cyp2c69 in the liver. Lower expression levels of the mouse Cyp2cs were also detected in other tissues. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28450579      PMCID: PMC5478903          DOI: 10.1124/dmd.117.075697

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

Review 3.  Gender-related differences in pharmacokinetics and their clinical significance.

Authors:  E Tanaka
Journal:  J Clin Pharm Ther       Date:  1999-10       Impact factor: 2.512

4.  CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products.

Authors:  Tracy C DeLozier; Cheng-Chung Tsao; Sherry J Coulter; Julie Foley; J Alyce Bradbury; Darryl C Zeldin; Joyce A Goldstein
Journal:  J Pharmacol Exp Ther       Date:  2004-04-14       Impact factor: 4.030

Review 5.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Authors:  D R Nelson; L Koymans; T Kamataki; J J Stegeman; R Feyereisen; D J Waxman; M R Waterman; O Gotoh; M J Coon; R W Estabrook; I C Gunsalus; D W Nebert
Journal:  Pharmacogenetics       Date:  1996-02

6.  Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines.

Authors:  Nico Scheer; Yury Kapelyukh; Lynsey Chatham; Anja Rode; Sandra Buechel; C Roland Wolf
Journal:  Mol Pharmacol       Date:  2012-08-23       Impact factor: 4.436

7.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

Authors:  W B Campbell; D Gebremedhin; P F Pratt; D R Harder
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

8.  The human intestinal cytochrome P450 "pie".

Authors:  Mary F Paine; Heather L Hart; Shana S Ludington; Robert L Haining; Allan E Rettie; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2006-02-07       Impact factor: 3.922

Review 9.  Biochemistry and molecular biology of the human CYP2C subfamily.

Authors:  J A Goldstein; S M de Morais
Journal:  Pharmacogenetics       Date:  1994-12

10.  Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions.

Authors:  Frederique Ponchel; Carmel Toomes; Kieran Bransfield; Fong T Leong; Susan H Douglas; Sarah L Field; Sandra M Bell; Valerie Combaret; Alain Puisieux; Alan J Mighell; Philip A Robinson; Chris F Inglehearn; John D Isaacs; Alex F Markham
Journal:  BMC Biotechnol       Date:  2003-10-13       Impact factor: 2.563

View more
  6 in total

1.  Expression of drug metabolizing enzymes and transporters in the cochlea: Implications for drug delivery and ototoxicity.

Authors:  Stefanie Kennon-McGill; Melissa M Clemens; Mitchell R McGill
Journal:  Hear Res       Date:  2019-05-15       Impact factor: 3.208

2.  Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.

Authors:  Akira Honda; Teruo Miyazaki; Junichi Iwamoto; Takeshi Hirayama; Yukio Morishita; Tadakuni Monma; Hajime Ueda; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Tadashi Ikegami
Journal:  J Lipid Res       Date:  2019-10-23       Impact factor: 5.922

3.  Tissue Distribution and Gender-Specific Protein Expression of Cytochrome P450 in five Mouse Genotypes with a Background of FVB.

Authors:  Jiamei M Chen; Qisong S Zhang; Xiaoyan Y Li; Xia Gong; Yanjiao J Ruan; Sijing J Zeng; Linlin L Lu; Xiaoxiao X Qi; Ying Wang; Ming Hu; Lijun J Zhu; Zhongqiu Q Liu
Journal:  Pharm Res       Date:  2018-04-10       Impact factor: 4.200

4.  Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice.

Authors:  Joan P Graves; J Alyce Bradbury; Artiom Gruzdev; Hong Li; Caroline Duval; Fred B Lih; Matthew L Edin; Darryl C Zeldin
Journal:  FASEB J       Date:  2019-11-05       Impact factor: 5.834

5.  Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel.

Authors:  William R Arnold; Lauren N Carnevale; Zili Xie; Javier L Baylon; Emad Tajkhorshid; Hongzhen Hu; Aditi Das
Journal:  Nat Commun       Date:  2021-02-10       Impact factor: 17.694

6.  Cyp2c44 epoxygenase-derived epoxyeicosatrienoic acids in vascular smooth muscle cells elicit vasoconstriction of the murine ophthalmic artery.

Authors:  Jiong Hu; Marco Sisignano; Roman Brecht; Natarajan Perumal; Carlo Angioni; Iris-Sofia Bibli; Beate Fisslthaler; Hartmut Kleinert; Norbert Pfeiffer; Ingrid Fleming; Caroline Manicam
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.